ניסטטין רדי מיקס ישראל - עברית - Ministry of Health

ניסטטין רדי מיקס

taro pharmaceutical industries ltd - nystatin - תרחיף - nystatin 100000 iu/ml - nystatin - nystatin - for the treatment of oral fungal infections.

אמריל 1 מג ישראל - עברית - Ministry of Health

אמריל 1 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 1 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אמריל 2 מג ישראל - עברית - Ministry of Health

אמריל 2 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 2 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אמריל 3 מג ישראל - עברית - Ministry of Health

אמריל 3 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 3 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אמריל 4 מג ישראל - עברית - Ministry of Health

אמריל 4 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 4 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אונגלייזה 5 מג ישראל - עברית - Ministry of Health

אונגלייזה 5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

אונגלייזה 2.5 מג ישראל - עברית - Ministry of Health

אונגלייזה 2.5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 2.5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

רפאגליניד טבע   0.5 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 0.5 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

רפאגליניד טבע   1 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 1 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.

רפאגליניד טבע   2 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 2 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 2 mg - repaglinide - repaglinide - treatment of type ii diabetes.